
Alexcure Lifesciences Private Limited
Produces and distributes pharmaceutical products, established in 2020, based in Chandigarh.
Produces and distributes pharmaceutical products, established in 2020, based in Chandigarh.
Alexcure Lifesciences Private Limited (ALPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 September 2020 (Four years and seven months 20 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Hardeep Nimber, Rohit Chauhan, and Mohit Kumar serve as directors at the Company.
Chandigarh, India
+91-XXXXXXXXXX
U24299CH2020PTC043215
043215
Private Limited Indian Non-Government Company
12 Sep 2020
30 Sep 2024
31 Mar 2024
Unlisted
Roc Chandigarh
Alexcure Lifesciences Private Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Aceclofenac, Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Common Disease Medicines, Antihistamines, Anti Infective Drugs & Medicines, Antibacterial Drugs, Cardiovascular Drugs & Medication, Diabetes Medicine.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Hardeep Nimber ![]() | Director | 12-Sep-2020 | Current |
Rohit Chauhan ![]() | Director | 12-Sep-2020 | Current |
Mohit Kumar ![]() | Director | 12-Sep-2020 | Current |
Alexcure Lifesciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 20.06% increase. The company also saw a substantial improvement in profitability, with a 11.02% increase in profit. The company's net worth Soared by an impressive increase of 125.92%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
Unlock access to Alexcure Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Hardeep Nimber is a mutual person
Hardeep Nimber is a mutual person
Hardeep Nimber is a mutual person
Hardeep Nimber, Rohit Chauhan and 1 more are mutual person
Rohit Chauhan is a mutual person
₹2.50 M
₹0
Date | Lender | Amount | Status |
---|---|---|---|
01 Jun 2023 | Hdfc Bank Limited | ₹2.50 M | Open |
Alexcure Lifesciences has a workforce of 0 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Alexcure Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alexcure Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Alexcure Lifesciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Alexcure Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh.
A charge with Hdfc Bank Limited of Rs. 2.50 M registered on 01 Jun 2023 with Charge ID 100744967 was modified on 19 Oct 2023.
A charge with Hdfc Bank Limited amounted to Rs. 2.50 M with Charge ID 100744967 was registered on 01 Jun 2023.
Hardeep Nimber was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 4 years 7 months .
Rohit Chauhan was appointed as a Director was appointed as a Director on 12 Sep 2020 & has been associated with this company since 4 years 7 months .
Alexcure Lifesciences Private Limited was incorporated on 12 Sep 2020.
The authorized share capital of Alexcure Lifesciences Private Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Alexcure Lifesciences Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Alexcure Lifesciences Private Limited is Scf 271, Motor Market Commercial Complex India, Manimajra, Chandigarh, 160101.
The corporate identification number (CIN) of Alexcure Lifesciences Private Limited is U24299CH2020PTC043215 and the company number is 043215 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Alexcure Lifesciences Private Limited has risen by 20.06%.
The financial reports for the fiscal year 2023 indicates that The net worth of Alexcure Lifesciences Private Limited has experienced an upsurge of 125.92%.
As per the financial statements for fiscal Year 2023, The total open charges for Alexcure Lifesciences Private Limited amount to ₹ 2.50 M.
The most recent Balance Sheet for Alexcure Lifesciences Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
VC